Yi Li – InmunoES

Mitochondrial quality control modulating chondrocyte behavior and fate in knee osteoarthritis: mechanistic insights and therapeutic prospects

25 de February de 2026 by Yi Li

Osteoarthritis (OA) is a highly prevalent and debilitating joint disorder that imposes a heavy burden on global public health due to its high incidence, prevalence, and disability rate, as well as the associated substantial healthcare costs. Early inte…

From metabolic reprogramming to epigenetic modification: association network and targeted treatment strategy between histone lactylation and tumor progression

17 de September de 2025 by Yi Li

Metabolic reprogramming and epigenetic modification have been widely observed in cancer research. Based on accumulating experimental evidence in recent years, beginning with metabolic reprogramming driven by carcinogenic signals, the accumulation of ke…

A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential

11 de October de 2024 by Yi Li

Ovarian cancer (OC) is one of the deadliest gynecological malignancies in the world and is the leading cause of cancer-related death in women. The complexity and difficult-to-treat nature of OC pose a huge challenge to the treatment of the disease, The…